Navigation Links
New England Journal of Medicine Publishes Results from Boston Scientific's Landmark SYNTAX(TM) Trial
Date:2/18/2009

Data show comparable safety for complex patients treated with TAXUS(R) Express2(TM) Stents and bypass surgery

NATICK, Mass., Feb. 18 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today welcomed the publication of results from its landmark SYNTAX(TM) trial in this week's issue of the New England Journal of Medicine. In the study, percutaneous coronary intervention (PCI) using the TAXUS(R) Express2(TM) Paclitaxel-Eluting Coronary Stent System was compared to contemporary coronary artery bypass graft (CABG) surgery in patients with the most complex coronary artery disease (CAD). Trial results at 12 months demonstrated no overall statistically significant differences between PCI and CABG in rates of death or myocardial infarction (heart attack), although PCI patients were more likely to require a repeat revascularization (mostly additional PCI) than were CABG patients.

The SYNTAX trial is the first randomized, controlled clinical trial to compare these two treatments in patients with left main disease and three-vessel disease. These patient groups are typically treated with CABG and represent a population with far more complex anatomy and advanced disease than those studied in prior drug-eluting stent (DES) clinical trials.

"SYNTAX has provided the medical community with critical information on the management of patients with advanced and complex CAD," said Ted Feldman, M.D., F.S.C.A.I., Director of the Cardiac Catheterization Laboratory at NorthShore University HealthSystem in Evanston, Illinois, and a lead investigator of the trial. "While CABG may still be the preferred treatment in many patients with complicated disease, some patients may now be candidates for the less-invasive alternative offered by stents. These data will assist cardiologists in making treatment therapy decisions for th
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. New England Journal of Medicine Publishes Results From the Landmark ATHENA Trial with Multaq(R) (dronedarone) in Atrial Fibrillation
2. Video: Zometa(R) Reduces Risk of Breast Cancer Recurrence in Premenopausal Women, Study in The New England Journal of Medicine Reports
3. Two New Studies in the New England Journal of Medicine Show Malaria Vaccine Candidate Advancing in Africa
4. Diamyd(R) Study Published in Prestigious New England Journal of Medicine
5. New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients
6. The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer
7. The New England Journal of Medicine Publishes Study Investigating the Safety and Efficacy of Baxters Cell-Based Pandemic, Avian Flu Vaccine
8. New England Journal of Medicine Publishes Results From a RELISTOR Phase 3 Clinical Study
9. Berkery Noyes Represented The Thomson Corporation in the Sale of CenterWatch and New England Institutional Review Board to Jobson Medical Information
10. New England Journal of Medicine Study Shows ERBITUX(R) Improves Survival in Advanced Colorectal Cancer
11. The New England Journal of Medicine Publishes First Clinical Results for MedImmunes Chitinase-like Protein YKL-40 in Patients With Asthma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... , July 29, 2014 McGraw-Hill Education Professional, ... the science, technical, and medical communities, has announced the ... off-line mobile application of the world-renowned medical education platform. ... AccessMedicine App , available for download onto all ... be able to gain access to valuable AccessMedicine ...
(Date:7/29/2014)... New York , July 29, 2014 ... by Transparency Market Research "Orthopedic Trauma Fixation Devices Market ... Analysis 2014 - 2020", the global orthopedic trauma fixation ... 2014 and is expected to grow at a CAGR ... estimated value of USD 9.3 billion in 2020. ...
(Date:7/29/2014)... , July 29, 2014  Instrumentation Laboratory (IL) today ... a new corporate logo. This is part of a comprehensive ... Founded in Boston, MA , in ... of companies since 1992.  Other companies in the group include ... and Systelab ( Barcelona, Spain ).  Like IL, ...
Breaking Medicine Technology:McGraw-Hill Education Professional's AccessMedicine App Delivers Instant Access to Essential Diagnostic Tools 2McGraw-Hill Education Professional's AccessMedicine App Delivers Instant Access to Essential Diagnostic Tools 3Orthopedic Trauma Fixation Devices Market is Expected to Reach USD 9.3 Billion Globally in 2020: Transparency Market Research 2Orthopedic Trauma Fixation Devices Market is Expected to Reach USD 9.3 Billion Globally in 2020: Transparency Market Research 3Orthopedic Trauma Fixation Devices Market is Expected to Reach USD 9.3 Billion Globally in 2020: Transparency Market Research 4Instrumentation Laboratory Unveils New Corporate Brand 2Instrumentation Laboratory Unveils New Corporate Brand 3
... , STAMFORD, Conn., Nov. 13 ... will be releasing a free trial version of its Zargis ... conference, taking place this November 15-17 in Orlando. Zargis is ... the companion hardware -- the 3M Littmann Electronic Stethoscope Model ...
... BERWYN, Pa., Nov. 13 /PRNewswire-FirstCall/ -- Encorium Group, ... multinational clinical research organization (CRO) conducting studies in over ... and biotechnology companies, today announced that it has appointed ... 7, 2009. Ms. Laitinen, age 43, will replace ...
Cached Medicine Technology:Zargis to Release Trial Version of Cardioscan while Exhibiting with 3M(TM) Littmann(R) at American Heart Association Conference 2Zargis to Release Trial Version of Cardioscan while Exhibiting with 3M(TM) Littmann(R) at American Heart Association Conference 3Encorium Group, Inc. Appoints Sari Laitinen to Board of Directors 2Encorium Group, Inc. Appoints Sari Laitinen to Board of Directors 3
(Date:7/29/2014)... Colorado (PRWEB) July 29, 2014 Daily ... that the program was actually created by a popular ... too. He tried numerous treatments for this disorder, but ... found himself in the situation of having to look ... years of research. Dawson used this method, too, to ...
(Date:7/29/2014)... Advertising claims for cosmetic procedures using stem cells ... safety and effectiveness, according to a review in the ... , the official medical journal of the ... cells offer tremendous potential, but the marketplace is saturated ... patients at risk," write Dr Michael T. Longaker of ...
(Date:7/29/2014)... Angeles, CA (PRWEB) July 29, 2014 ... the website of Time Magazine titled “From Kim’s Butt ... Kim Kardashian’s butt is the celebrity feature ... and their features include Beyoncé’s butt, Jennifer Lawrence’s ... lips. This information is based on data collected by ...
(Date:7/29/2014)... 29, 2014 Tylenol lawsuits ( ... allegedly suffered serious liver injuries due to the ... in a multidistrict litigation underway in U.S. District ... reports. According to an Order dated July 23rd, ... to bellwether case and discovery issues. Among other ...
(Date:7/29/2014)... Avenidas is always looking for ... again, the non-profit agency is doing just that with the ... , This event gives seniors the opportunity to learn about ... will be a variety of fun activities, including a Tai ... and artists. In addition, there will be food tastings, courtesy ...
Breaking Medicine News(10 mins):Health News:Natural Vitiligo Treatment System Review Reveals Michael Dawson’s New Vitiligo Cure Program 2Health News:Beware of claims about cosmetic stem cells procedures, says review in Plastic and Reconstructive Surgery 2Health News:Celebrity Plastic Surgery: Kim Kardashian’s Butt Tops the List of Celebrity Plastic Surgery Requests 2Health News:Tylenol Lawsuit News: Federal Court Overseeing Tylenol Liver Damage Claims Sets New Deadlines Pertaining to Discovery, Bellwether Trials, Bernstein Liebhard LLP Reports 2Health News:Tylenol Lawsuit News: Federal Court Overseeing Tylenol Liver Damage Claims Sets New Deadlines Pertaining to Discovery, Bellwether Trials, Bernstein Liebhard LLP Reports 3Health News:Tylenol Lawsuit News: Federal Court Overseeing Tylenol Liver Damage Claims Sets New Deadlines Pertaining to Discovery, Bellwether Trials, Bernstein Liebhard LLP Reports 4Health News:Avenidas Hosts Third Annual Successful Aging Celebration 2
... Total hip arthroplasty (THA), or hip replacement, is ... studies have only followed patients for up to ... December issue of Arthritis Care & Research ( ... eight years following hip replacement and found a ...
... obtained agreement with the United States, Food and Drug ... SP1049C for the treatment of metastatic adenocarcinoma of the ... upper gastrointestinal tract, ... clinical trial will compare SP1049C plus Best Supportive Care (BSC),versus BSC ...
... Flick, presents World AIDS Day Special ... SIRIUS Satellite Radio,Interview with Madonna and exclusive performances from Cyndi Lauper, Indigo ... Bell and others, NEW YORK, Nov. 28 SIRIUS Satellite Radio,(Nasdaq: ... --,Saturday, December 1 -- with an exclusive broadcast event on SIRIUS OutQ,109, ...
... Over the past few weeks,there has been a ... the meat industry and the USDA that permits ... failed to be "non-negative" for E.,coli O157:H7,( http://www.ehagroup.com/epidemiology/illnesses/e-coli-O157-H7.asp ... includes cooking to the thermal death,stage for all ...
... Breast cancer is a disease with a number ... have seen that these risks are often compounded by ... exactly, do social disadvantages, genetics, race and culture add ... women? , These are among the questions in ...
... of Americans still weigh much too much, study finds , , ... hasn,t increased much in recent years, but there are still ... study reports. , The study, based on 2005-06 data from ... , More than a third of American adults (about 72 ...
Cached Medicine News:Health News:Long-term improvement seen with hip replacement 2Health News:Supratek Pharma Inc. announced today that under the Special Protocol 2Health News:SIRIUS OutQ Honors International Day of AIDS Awareness 2Health News:SIRIUS OutQ Honors International Day of AIDS Awareness 3Health News:The USDA 'E. coli Loophole' in Ground Beef: Much Ado About Nothing 2Health News:The USDA 'E. coli Loophole' in Ground Beef: Much Ado About Nothing 3Health News:New perspectives on health disparities in breast cancer research 2Health News:New perspectives on health disparities in breast cancer research 3Health News:New perspectives on health disparities in breast cancer research 4Health News:New perspectives on health disparities in breast cancer research 5Health News:New perspectives on health disparities in breast cancer research 6Health News:New perspectives on health disparities in breast cancer research 7Health News:New perspectives on health disparities in breast cancer research 8Health News:Obesity Rates Leveling Off Among U.S. Adults 2
... Philadelphia™ Collar and Stabilizer Plastazote® ... reinforcements. Hook-and-pile closure straps. Chin ... mandibular pieces may be interchanged ... easily to the standard Philadelphia ...
Urethrotome - non-optical...
Optical Urethrotome for Telescope 2.7 mm for children....
... The USA Elite ... Visual Urethrotomes are utilized ... strictures and bladder neck ... The visual obturator converts ...
Medicine Products: